- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03490747
Evaluation of a Physical Activity Referral Scheme
Clinical and Cost-effectiveness of a Co-developed, Evidence-based Physical Activity Referral Scheme for the Treatment and Prevention of Health Conditions: a Pragmatic Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Evidence of effectiveness for UK exercise referral is unclear. This representation has been deemed an unfair assessment of its potential to impact public health. This is due to systematic review evidence that reports evaluations of exercise referral interventions that are not evidence-based or underpinned by behaviour change theory.
This evaluation is the third phase of a project that aims to co-develop (Phase 1), pilot (phase 2) and evaluate (phase 3) an evidence-based exercise referral scheme. This approach is underpinned by the Medical Research Council guidance for complex interventions.
Through co-development work with a multidisciplinary group of researchers and local stakeholders and subsequent pilot work, it is hypothesised that the co-developed, evidence-based intervention will have improved chances of implementation success, and therefore, clinical effectiveness.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Merseyside
-
Liverpool, Merseyside, United Kingdom, L3 2AT
- Liverpool John Moores University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• 18 years or older and have a health-related risk factor (e.g. high blood pressure, hyperglycaemia, obesity etc.) or a health condition (diabetes, cardiovascular disease, anxiety, depression etc.) that may be alleviated by increasing current PA levels.
Exclusion Criteria:
- Uncontrolled health-conditions (Cardiac, metabolic, respiratory etc.) and/or any recent traumatic events (e.g. myocardial infarction).
- Unstable angina or aortic stenosis.
- Severe psychological or neurological conditions.
- Participation in an ERS at any location other than the research centres (at the time of recruitment).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Co-developed referral scheme
A physical activity referral scheme co-developed by multidisciplinary stakeholders to incorporate behaviour change support and ensure pragmatic relevance and feasibility.
|
An 18-week physical activity referral scheme co-developed by a local multidisciplinary stakeholder group.
Behaviour change support underpinned by Self-Determination Theory (Ryan & Deci, 2000) will be provided by an exercise referral practitioner at weeks 1,4,8,12 and 18 to facilitate increased physical activity levels.
Patients will be supported to develop a tailored programme of physical activity that may involve use of the fitness centre facilities (e.g.
swimming, group classes, gymnasium use), participation in community-based initiatives, and changes to habitual physical activity.
Focus on promoting patient autonomy and tailoring activities to patient's preferences and needs.
Subsidised access to fitness centre facilities for first 12 weeks.
|
Active Comparator: Usual care referral scheme
Comparative, usual care exercise referral scheme.
|
A comparative usual care exercise referral scheme that includes fitness centre based activities (e.g.
swimming, group classes, gymnasium use).
Patients meet an exercise referral practitioner at their induction (week 1) and week 12 (post scheme).
Patients are typically prescribed a gym-based, 12-week programme.
Subsidised access to fitness centre facilities for 12 weeks.
|
No Intervention: No treatment control
Lifestyle advice leaflet only (provided to participants in all arms during baseline assessments).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in cardiorespiratory fitness
Time Frame: Baseline and week 12.
|
Estimated via the Astrand-Rhyming cycle protocol using the updated age and sex specific nomogram.
|
Baseline and week 12.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in objective physical activity levels
Time Frame: Baseline, week 12, and 6 months
|
Objective physical activity levels will be analysed using a hip worn accelerometer (ActiGraph GT3X).
7-day monitoring periods will recorded at three time points.
During the 7-day monitoring period, each participant will complete a diary to record hours of use and to distinguish between work and leisure hours.
|
Baseline, week 12, and 6 months
|
Change in flow-mediated dilation
Time Frame: Baseline and week 12.
|
Endothelium dependent vasodilatation of the brachial arteries will be examined using ultrasound.
Brachial artery baseline diameter and blood flow will be assessed in one arm.
An ultrasound probe is placed on the bicep for 1 minute before a blood pressure cuff (placed around the forearm) is inflated to suprasystolic pressure (~220 mmHg) for 5 minutes.
Immediately after the cuff is deflated, changes in arterial diameter and flow will be assessed continuously for 3 minutes using the ultrasound probe.
Ultrasound data will then be analysed post hoc.
|
Baseline and week 12.
|
Change in carotid vasoreactivity
Time Frame: Baseline and week 12.
|
The carotid vasoreactivity (cold pressor) test will measure the carotid artery's response to a stimulus.
Similar to the flow-mediated dilation procedure, an ultrasound probe will be placed on the patient's left side of their neck, positioned in such a way to allow a clear image of the right common carotid artery to be displayed on the ultrasound monitor screen.
The cold pressor procedure involves submersion of the left hand to wrist in ice slush for 180-seconds.
Ultrasound data will then be analysed post hoc.
|
Baseline and week 12.
|
Change in total cholesterol
Time Frame: Baseline and week 12.
|
A 15ml blood sample will be taken.
Blood profiles will be analysed as a measure of cardiometabolic health.
Analysis will be conducted at LJMU.
Patients will be made aware of the storage and use of their tissue.
|
Baseline and week 12.
|
Change in plasma glucose
Time Frame: Baseline and week 12.
|
A 15ml blood sample will be taken.
Blood profiles will be analysed as a measure of cardiometabolic health.
Analysis will be conducted at LJMU.
Patients will be made aware of the storage and use of their tissue.
|
Baseline and week 12.
|
Change in triglycerides
Time Frame: Baseline and week 12.
|
A 15ml blood sample will be taken.
Blood profiles will be analysed as a measure of cardiometabolic health.
Analysis will be conducted at LJMU.
Patients will be made aware of the storage and use of their tissue.
|
Baseline and week 12.
|
Change in self-reported physical activity
Time Frame: Baseline, week 12, and 6 months.
|
Patients' perceived physical activity levels will be recorded with the short version of the International Physical Activity Questionnaire (IPAQ, Craig et al., 2003).
The short-IPAQ is a 7-day recall self-administered tool that measures intensity, frequency and duration of physical activity and provides a total estimate of energy expenditure.
A total score of MET-minutes/day/week and sedentary behaviour minutes/day/week will be calculated according to the IPAQ scoring protocol.
|
Baseline, week 12, and 6 months.
|
Change in psychological wellbeing
Time Frame: Baseline, week 12, and 6 months.
|
Psychological wellbeing will be measured using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS, Tennant et al., 2007).
WEMWBS is a 14-item positively worded instrument containing items related to psychological functioning (e.g.
"I've been thinking clearly") and subjective well-being (e.g.
"I've been feeling cheerful").
Participants are asked to rate on a Likert scale of 1 (none of the time) to 5 (all of the time) how well each statement describes their experiences over the last two weeks.
|
Baseline, week 12, and 6 months.
|
Attendance at consultations
Time Frame: Week 1, 4, 8, 12, and 18
|
Patient attendance records will be collected by ERPs at the following time-points:
|
Week 1, 4, 8, 12, and 18
|
Attendance at fitness centre
Time Frame: Week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12. Months 4, 5 and 6
|
The number of times patients sign in at the fitness centre to go to either the gym or a class will be recorded on a weekly basis for weeks 1 to 12, then on a monthly basis up to 6 months.
This information is automatically recorded at fitness centres when patients visit.
|
Week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12. Months 4, 5 and 6
|
Fidelity - consultation attendance
Time Frame: Week 18
|
ERPs from both intervention and usual care centres will be asked to monitor the number of consultations offered (measured by appointment bookings or records of appointments offered but declined by participants), and the number of consultations conducted for each patient.
|
Week 18
|
Fidelity - consultation communication strategies
Time Frame: Week 1, 4, 8, 12, and 18
|
A random sample of ERS inductions from both intervention and usual care centres (approx 10 per centre) plus a random sample of 4, 8, 12 and 18-week consultations from the intervention centre only will be audio-recorded and coded for the use of "needs-supportive" communication strategies (using a coding manual developed through a previous pilot study (REF 16/WA/0231)).
In addition, all intervention centre recordings will be coded for fidelity to an agreed protocol, e.g.
asking required questions about physical activity, setting an action plan, giving out patient log book etc.
|
Week 1, 4, 8, 12, and 18
|
Change in health-related quality of life measure
Time Frame: Baseline, week 12, and 6 months.
|
Participants' change in health-related quality of life (HRQoL) will be measured at baseline, 12 weeks, and 6 months.
The EQ-5D will be used, this is a validated tool for measuring HRQoL.
This tool has been applied successfully in a recent UK trial-based economic evaluation of exercise referral schemes (Edwards et al. 2013).
|
Baseline, week 12, and 6 months.
|
Intervention operating and set up costs
Time Frame: Week 18
|
Captured via telephone interview with Exercise Referral Scheme Personnel from (organisation e.g.
local authority/ fitness centre/ research institute; questions adapted from validated questionnaire).
|
Week 18
|
Loss in revenue costs
Time Frame: Week 18
|
Captured via telephone interview with fitness centre manager and/or coordinators (questions have been used in previous research).
|
Week 18
|
Change in patient costs
Time Frame: Baseline, Week 12 and 6 months
|
Captured via patient questionnaire during lab testing (questions adapted from validated questionnaire).
|
Baseline, Week 12 and 6 months
|
Change in patient health care utilisation costs
Time Frame: Baseline and 6 months
|
Captured via questionnaire (questions adapted from validated questionnaire).
|
Baseline and 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in exercise motivation
Time Frame: Baseline, week 12, and 6 months.
|
The Behavioural Regulation in Exercise Questionnaire (BREQ-2, Markland & Tobin, 2004) plus 4 additional items (Wilson et al., 2006a) will be used to assess exercise motivation.
The BREQ-2 is a widely-used instrument comprised of 19 items describing reasons why people exercise (e.g.
"I think exercising is a waste of time"; "I feel ashamed when I miss an exercise session"; "I exercise because it's fun").
Participants answer on a likert scale of 0 (not true for me) to 4 (very true to me) to indicate how true each item is for them.
|
Baseline, week 12, and 6 months.
|
Change in psychological needs satisfaction
Time Frame: Baseline, week 12, and 6 months.
|
Psychological need satisfaction will be measured using the Psychological Need Satisfaction in Exercise Scale (PNSE, Wilson et al., 2006b).
The PNSE is an 18-item instrument designed to measure participants' perceived autonomy (e.g.
"I feel free to exercise in my own way"), competence (e.g.
"I feel capable of completing exercises that are challenging to me") and relatedness (e.g.
"I feel connected to the people who I interact with while we exercise together") in an exercise context.
Participants are asked to answer on a 6-point likert scale (1 = false, 6 = true) to indicate how they typically feel when they exercise.
|
Baseline, week 12, and 6 months.
|
Change in perceived needs support
Time Frame: Baseline, week 12, and 6 months.
|
Needs support will be measured using a 15-item needs support (NS) tool developed by Markland and Tobin (2010) to measure the extent to which participants perceive their exercise instructors provide support for autonomy, structure (linked to competence) and involvement (linked to relatedness).
|
Baseline, week 12, and 6 months.
|
Change in intentions to engage in physical activity
Time Frame: Baseline, week 12, and 6 months.
|
Three items developed by Edmunds et al. (2007) will be used to assess patients' intentions to engage in PA (e.g.
"I plan to regularly engage in PA during the next 3 months").
|
Baseline, week 12, and 6 months.
|
Patient focus groups - intervention
Time Frame: Week 12
|
Focus groups will be conducted with a purposeful subsample of patients after approximately 6-12 weeks of attending the scheme (e.g.
those with low attendance, high attendance, significant health changes, no change etc.).
Two focus groups will be conducted with patients attending the intervention centre (approx 5-8 participants per group).
Focus groups will be conducted at the individual fitness centres and will last approximately 60 minutes.
Discussion will focus on the extent to which, and how, patients feel each ERS is facilitative (or not) in helping them become more physically active, with questions about staff interactions, activities on offer, and the impact of the scheme on their likely continuation with physical activity.
|
Week 12
|
Patient focus groups - usual care
Time Frame: Week 12
|
Focus groups will be conducted with a purposeful subsample of patients after approximately 6-12 weeks of attending the scheme (e.g.
those with low attendance, high attendance, significant health changes, no change etc.).
Two focus groups will be conducted with patients attending the usual care centre (approx 5-8 participants per group).
Focus groups will be conducted at the individual fitness centres and will last approximately 60 minutes.
Discussion will focus on the extent to which, and how, patients feel each ERS is facilitative (or not) in helping them become more physically active, with questions about staff interactions, activities on offer, and the impact of the scheme on their likely continuation with physical activity.
|
Week 12
|
Exercise referral practitioner (ERP) interviews (intervention group only)
Time Frame: Week 18
|
ERPs from the intervention centre only will take part in a semi-structured interview (after over half of patients have reached the 18-week point).
The interviews will aim to explore the acceptability of the co-developed intervention, any challenges of delivery, and areas that require further development etc.
|
Week 18
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SPS-17-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Lawson Health Research InstituteTerminated
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
Clinical Trials on Physical activity referral scheme
-
University of Erlangen-NürnbergRecruitingNon-Communicable Chronic DiseasesGermany
-
University of California, BerkeleyCompleted
-
McMaster UniversityCompleted
-
Copenhagen University Hospital, HvidovreUniversity of Copenhagen; Sygekassernes Helsefond; The Danish Rheumatism Association and other collaboratorsRecruitingOsteoarthritis, KneeDenmark
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Centre Hospitalier Universitaire DijonWithdrawn
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
AUSL Romagna RiminiFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruitingNon-Small Cell Lung CancerItaly
-
Fundación para la Investigación del Hospital Clínico...CompletedObesity | Severe Mental Disorder